ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
Hailong Sheng(Nanfang Hospital), Chuanhui Cao(Nanfang Hospital), Yan Huang(Guilin Medical University), Yazhi Xiao(Nanfang Hospital), Ze-Qin Guo(Nanfang Hospital), Jian Wang(Qilu Hospital of Shandong University), Hui Wang, Wanjun Zhang(Zhengzhou University), Jingyuan Sun(Nanfang Hospital), Peitao Zhou(Nanfang Hospital), Mengying Shen(Nanfang Hospital), Wencong Dai(Nanfang Hospital), Zhenru Zhu(Beijing University of Technology)
Cited by 225
Related Papers
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
|Molecular Cancer|2020|333
The Long Intergenic Noncoding RNA UFC1, a Target of MicroRNA 34a, Interacts With the mRNA Stabilizing Protein HuR to Increase Levels of β-Catenin in HCC Cells
|Gastroenterology|2014|231
A New Self-Healing Hydrogel Containing hucMSC-Derived Exosomes Promotes Bone Regeneration
|Frontiers in Bioengineering and Biotechnology|2020|147
miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1
|Oncogene|2018|142
mTOR Complex-2 Activates ENaC by Phosphorylating SGK1
|Journal of the American Society of Nephrology|2010|125